In today’s briefing:
- Why Is India’s Paint Giant Asian Paint Falling?
- Carraro India Pre-IPO – Strategic Partnerships and Related Party Risks
- Rubber Cultivation Goes Up In Leaps And Bounds In India’s Northeast
- Lucror Analytics – Morning Views Asia
- Suraksha Diagnostic IPO: Premium Valuation Limits Near-Term Upside Potential
Why Is India’s Paint Giant Asian Paint Falling?
- Asian Paints (APNT IN) reported a 42.4% drop in Q2FY25 net profit and a 5.3% revenue decline.
- Intense competition, extended monsoons, weak urban demand, and margin pressures are impacting performance.
- Asian Paints’ resilience hinges on premiumization, sustainability, and industrial coatings to offset short-term challenges.
Carraro India Pre-IPO – Strategic Partnerships and Related Party Risks
- Carraro India Limited (810618Z IN) is looking to raise about US$216m in its India IPO.
- Carraro India Limited (CIL), is an independent tier 1 solution provider of axles, transmission systems and gears for the agricultural tractor and construction vehicle industries in India.
- In this note, we talk about the company’s historical performance.
Rubber Cultivation Goes Up In Leaps And Bounds In India’s Northeast
- INROAD project prompts Tripura to extend CM’s Rubber Mission
- Nagaland aims to cover 30,000 hectares with rubber by 2030
- Northeast starts getting saplings from its own nurseries
Lucror Analytics – Morning Views Asia
- In today’s Morning Views publication we comment on developments of the following high yield issuers: Adani Ports, Vedanta Resources, Seazen Group
- In the US, October new home sales fell 17.3% m-o-m (-1.8% e / 7.0% revised p) to an annualised 610 k units, the lowest in almost two years, amid rising mortgage rates as well as disruptions caused by hurricanes Helene and Milton. Separately, the Conference Board consumer confidence index increased to 111.7 in November (111.8 e / 109.6 p), the highest since August 2023.
- “November’s increase was mainly driven by more positive consumer assessments of the present situation, particularly regarding the labour market. Compared to October, consumers were also substantially more optimistic about future job availability, which reached its highest level in almost three years”, according to Dana M. Peterson, Chief Economist at The Conference Board.
Suraksha Diagnostic IPO: Premium Valuation Limits Near-Term Upside Potential
- Suraksha Diagnostic (1481262D IN) offers a one-stop integrated solution for pathology and radiology testing, and medical consultation services in Eastern and North Eastern states of India.
- The IPO comprises only an offer for sale of up to 19M equity shares, with no fresh issue. Suraksha Diagnostic has set price band of INR420–441 per share.
- The floor price of the IPO reflects fair value of the company and discounts all near-term growth catalyst. We would advise not to subscribe the issue for listing gain.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
